Valneva valneva.com

Valneva, formerly Vivalis, is a new European biotech company focusing on vaccines and antibodies, striving to become a leader in its field. It was created in 2013 through the merger between Intercell and Vivalis, combining two value propositions – antibody discovery and vaccines development and commercialization.

Valneva, formerly Vivalis, is a new European biotech company focusing on vaccines and antibodies, striving to become a leader in its field. It was created in 2013 through the merger between Intercell and Vivalis, combining two value propositions – ...Show all

See All Exits Recent Exits

Phone: +33 4 78 76 61 01

Fax:

Gerland Plaza Techsud
70, rue Saint Jean de Dieu
Lyon, 69007
France

Valneva - Investments & Acquisitions

Show Real Data Valneva Investments
See all Recent Investments
Date Company Round Amount Co-investors
2015-01-20BliNK BiomedicalSeries A$4.4MCancer Research Technology, IDInvest Partners, and Kurma Partners
2015-01-06Crucell SwedenAcquired
2013-05-29IntercellAcq - P2P
See all 3 investments